COMT and Parkinson disease: Considering the involvement of COMT and MAO in dopamine metabolism, Zou et al. developed a series of novel dual inhibitors inspired by the nitrocatechol scaffold, aiming to identify multitarget candidates for Parkinson’s disease treatment.